Literature DB >> 30033133

1:1 atrial flutter induced by flecainide, whilst the patient was at rest.

Ivan Comelli1, Federica Pigna1, Gianfranco Cervellin2.   

Abstract

Class Ic antiarrhythmic agents flecainide and propafenone are amongst the drugs most frequently prescribed to control atrial arrhythmias, in particular atrial fibrillation (AF). Despite being cited in some guidelines as a warning when using 1c antiarrhythmic agents, atrial flutter (AFl) with 1:1 atrioventricular conduction is rare in adults, with only small series reported in the literature, mainly including patients having 1:1 AFl during physical activity, and often associated with a predisposing factor, namely a dual AV nodal conduction pathway. We describe here a rare case of 1:1 AFl induced by flecainide, developing whilst the patients was resting in bed, in a 56 year old man who presented to the local Emergency Department (ED) complaining for palpitations due to acute-onset AF. After ED discharge, the patient was then evaluated in the Arrhythmologic Clinic of the Cardiology Department, and channellopaties were excluded. This case report should raise alertness in emergency physicians about this serious and potentially fatal side effect of flecainide, when using this drug for pharmacological cardioversion of AF.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  1:1 atrial flutter; 1c-dependent atrial flutter; Atrial fibrillation; Atrial flutter; Flecainide

Mesh:

Substances:

Year:  2018        PMID: 30033133     DOI: 10.1016/j.ajem.2018.07.040

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  2 in total

Review 1.  Revisiting an Underrecognized Strategy for Rhythm Management: Hybrid Therapy for Patients who Convert from Atrial Fibrillation to Flutter on Antiarrhythmic Drugs.

Authors:  Fady S Riad; Albert L Waldo
Journal:  J Innov Card Rhythm Manag       Date:  2019-10-15

2.  Atrial flutter with flecainide-induced 1:1 conduction at a rate <200 b.p.m. at rest: a case report.

Authors:  Sotirios Dardas; Asif Khan
Journal:  Eur Heart J Case Rep       Date:  2021-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.